The United Laboratories International Holdings (TUL) Ltd (3933 HK) - Retain Buy
​United Laboratories has seen significant price appreciation and success in diabetes and obesity strategy, with a promising pipeline for future...
403 Views
Hansoh Pharma Placement - Somewhat Expected but Still Opportunistic
Hansoh Pharmaceutical Group (3692 HK) aims to raise around US$500m via a primary placement. In this note, we talk about the deal dynamics.
713 Views
Curator's Cut: China Healthcare Rally, Financial Market Infra Moves & Korea’s Equity Upswing
This ​Curator's Cut issue shows what's contributed to the Chinese healthcare sector's performance YTD, looks at some exchanges and depositories,...
658 Views
ECM Weekly (21 July 2025) - Muyuan, Unisplendour, NTT, Kasumigaseki, Anthem, Leads, SBI, Ascentage
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
769 Views
United Lab Placement - Industry Momentum Strong, Although Stock Has Run-Up Quite a Bit
United Laboratories International Holdings is looking to raise up to US$262m from a primary placement. In this note, we will talk about the...
709 Views